Blinatumomab in refractory SLE-associated immune thrombocytopenia.
- DOI
- 10.1016/j.ard.2026.08.004
- Published
- 2026 Sep 1
- Container
- Annals of the rheumatic diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ard.2026.08.004,
title = {Blinatumomab in refractory SLE-associated immune thrombocytopenia.},
author = {Phithak E and Biesen R and Albach FN and Boeckel V and Minopoulou I and Wiebe E and Cheng Q and Sattle A and Rehm M and Sinzinger B and Beenken AE and Staeck A and Kleyer A and Hütter-Krönke ML and Busse A and Keller U and Krönke G and Simon D and Alexander T},
year = {2026},
journal = {Annals of the rheumatic diseases},
doi = {10.1016/j.ard.2026.08.004},
url = {https://doi.org/10.1016/j.ard.2026.08.004}
}RIS
TY - JOUR TI - Blinatumomab in refractory SLE-associated immune thrombocytopenia. AU - Phithak E AU - Biesen R AU - Albach FN AU - Boeckel V AU - Minopoulou I AU - Wiebe E AU - Cheng Q AU - Sattle A AU - Rehm M AU - Sinzinger B AU - Beenken AE AU - Staeck A AU - Kleyer A AU - Hütter-Krönke ML AU - Busse A AU - Keller U AU - Krönke G AU - Simon D AU - Alexander T PY - 2026 JO - Annals of the rheumatic diseases DO - 10.1016/j.ard.2026.08.004 UR - https://doi.org/10.1016/j.ard.2026.08.004 ER -
APA
E, P., R, B., FN, A., V, B., I, M., E, W., Q, C., A, S., M, R., B, S., AE, B., A, S., A, K., ML, H., A, B., U, K., G, K., D, S., & T, A. (2026). Blinatumomab in refractory SLE-associated immune thrombocytopenia.. Annals of the rheumatic diseases. https://doi.org/10.1016/j.ard.2026.08.004
Source records
- pubmed · retrieved 2026-09-26T02:59:02.454Z